Valuation : Alpa Laboratories Limited

Market Cap 98Cr 1.03Cr 88.46L 83.06L 75.82L 1.42Cr 1.43Cr 9.84Cr 3.83Cr 50Cr 3.86Cr 3.77Cr 164.13Cr P/E 2024
10.4x
P/E 2025 11.2x
Enterprise Value -15Cr -15.69L -13.51L -12.69L -11.58L -21.75L -21.91L -1.5Cr -58.49L -7.57Cr -58.92L -57.64L -25Cr EV / Sales 2024
0.81x
EV / Sales 2025 0.94x
Free-Float
42.71%
Yield 2024 *
-
Yield 2025 -
13/08 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
23/07 Alpa Laboratories Ltd. Announces Cessation of Ms. Jyoti Jain as an Independent Director, Effective July 21, 2026 CI
08/07 Alpa Laboratories Limited Announces Resignation of Yashoda Patidar as Company Secretary and Compliance Officer, Effective July 26, 2026 CI
29/05 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
11/04 Alpa Laboratories Limited Appoints Ms. Yashoda Patidar as Company Secretary and Compliance Officer, Effective April 11, 2026 CI
25/02 Alpa Laboratories Limited Announces Resignation of Srashti Chopra as Company Secretary and Compliance Officer, Effective March 25, 2026 CI
12/02 Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
13/25/13 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
01/25/01 Brookfield India Real Estate Trust announced that it expects to receive INR 10.00000015 billion in funding from a group of investors CI
28/25/28 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
14/25/14 Alpa Laboratories Limited Announces Change in Designation of Vitthal Kothana from Non- Executive Director to Executive Director CI
13/25/13 Alpa Laboratories Limited Appoints Srashti Chopra as Company Secretary and Compliance Officer CI
13/25/13 Alpa Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2024 CI
1 day-1.59%
1 week+0.11%
Current month-7.65%
1 month-7.65%
3 months-11.43%
6 months-2.11%
Current year-20.54%
1 week 60.61
Extreme 60.61
65.3
1 month 60.05
Extreme 60.05
72.5
Current year 46.1
Extreme 46.1
80.08
1 year 46.1
Extreme 46.1
99
3 years 46.1
Extreme 46.1
144.5
5 years 46.1
Extreme 46.1
144.5
10 years 11
Extreme 11
144.5
Manager TitleAgeSince
Chief Executive Officer - 28/05/2016
Director of Finance/CFO 65 -
Director TitleAgeSince
Chairman 83 -
Director/Board Member 77 01/01/1967
Director/Board Member - 28/05/2016
Change 5-day change 1-year change 3-year change Capi.($)
-1.59%+0.11%-35.94%-21.41% 1.39Cr
-2.81%+0.99%+23.39%+73.53% 5TCr
+1.14%+1.47%+56.16%+123.40% 4.03TCr
+0.56%+5.80%+17.83%+86.59% 1.22TCr
+0.98%-1.04%-10.35%+13.15% 1.2TCr
+0.19%-.--%+29.35%+150.00% 924.83Cr
-0.23%-1.73%+25.12%+48.44% 761.82Cr
-0.39%+3.33%+28.21%+222.15% 735.54Cr
+1.43%+1.70%+45.95%-9.99% 720.79Cr
-0.84%-2.36%-36.62%+16.04% 525.95Cr
Average -0.16%+1.17%+14.31%+70.19% 1.51TCr
Weighted average by Cap. -0.48%+1.77%+28.68%+87.75%

Financials

2024 2025
Net sales 108.74Cr 1.14Cr 98.4L 92.39L 84.34L 1.58Cr 1.6Cr 11Cr 4.26Cr 55Cr 4.29Cr 4.2Cr 182.57Cr 112.45Cr 1.18Cr 1.02Cr 95.55L 87.22L 1.64Cr 1.65Cr 11Cr 4.41Cr 57Cr 4.44Cr 4.34Cr 188.81Cr
Net income 17Cr 17.63L 15.18L 14.25L 13.01L 24.44L 24.62L 1.69Cr 65.72L 8.51Cr 66.2L 64.76L 28Cr 20Cr 20.5L 17.65L 16.57L 15.13L 28.42L 28.62L 1.96Cr 76.4L 9.89Cr 76.96L 75.29L 33Cr
Net Debt -88Cr -92.07L -79.28L -74.44L -67.95L -1.28Cr -1.29Cr -8.82Cr -3.43Cr -44Cr -3.46Cr -3.38Cr -147.09Cr -112.69Cr -1.18Cr -1.02Cr -95.74L -87.4L -1.64Cr -1.65Cr -11Cr -4.41Cr -57Cr -4.45Cr -4.35Cr -189.2Cr
Logo Alpa Laboratories Limited
Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
Employees
453
Date Price Change Volume
01/26/01 61.73 -1.59% 15,807
31/26/31 ₹62.73 -1.63% 12,779
28/26/28 ₹63.77 +4.23% 21,708
27/26/27 ₹61.18 -0.44% 7,422
26/26/26 ₹61.45 -1.03% 10,657
  1. Stock Market
  2. Stocks
  3. ALPA Stock